drugset / Trial / NCT05221164

162 mg of Aspirin for Prevention of Preeclampsia

NCT05221164 ↗

NaSingle-groupOpen-labelPrevention

Summary

This is a study to assess if 162 mg of aspirin will decrease rates of preeclampsia in pregnant patients compared to 81 mg of aspirin.

Timeline

Start
2021-07-06
Primary completion
2022-06-09
Completion
2022-06-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 162 mg —

Indications